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Abstract Increased membrane lipid peroxidation has recently 
been implicated as being associated with apoptosis. In the present 
study the addition of 15-hydroperoxyeicosatetraenoic ac d (15- 
HPETE) or 13-hydroperoxydodecadienoic acid (13-HPODE) to 
A3.01 T cells is shown to induce marked chromatin condensation 
coincident with DNA fragmentation, indicative of apoptosis. 15- 
HPETE also evoked an immediate and sustained rise in cytoplas- 
mic calcium which was required for the induction of apoptosis. 
A3.01 cells transfected with the bcl-2 proto-oncogene were 6- to 
8-fold more resistant o apoptotic killing by tumor necrosis fac- 
tor-a, but only 0.4-fold more resistant o 15-HPETE. Thus, Bcl-2 
is not capable of protecting cells from undergoing apoptosis fol- 
lowing the direct addition of lipid hydroperoxides. 
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1. Introduction 
Apoptosis is a form of cell death which is defined by, and is 
the result of, a temporal program of cellular events [1,2]. Nu- 
merous experimental model systems of inducing apoptosis have 
been reported, and although the stimuli which induce the apop- 
totic death program vary widely, the morphological features of 
cells undergoing apoptotic death appear to be highly conserved, 
suggesting that a single common death program may exist. 
Apoptosis-defining morphological changes occur at several 
sites within the cell [3]. Within the nucleus, wherein the chroma- 
tin of the dying cell condenses, first into a distinctive crescent- 
shaped pattern along the inner margins of the nuclear mem- 
brane, and then into a dense body which eventually breaks 
apart into a number of nuclear fragments. Coincident with 
these changes taking place in gross nuclear morphology, al- 
though possibly via a different pathway [4], the DNA is cleaved 
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by a Ca2+-dependent endonuclease at internucleosomal sites, 
generating a distinctive 'ladder' of 180-bp repeats often consid- 
ered to be pathognomonic of apoptotic death. 
Collective evidence has led to the suggestion that oxidative 
stress is a common mediator of apoptosis, perhaps via the 
formation of lipid hydroperoxides [5 7]. Indeed, lipid hydro- 
peroxides are known to be toxic [7,8], to increase cytosolic Ca 2+ 
[9,10], and to promote DNA fragmentation [7,11,12]. Neverthe- 
less, it is a subject of debate as to whether something as seem- 
ingly nonspecific and uncontrolled as membrane peroxidation 
could result in a structured form of cell death such as that which 
occurs during apoptosis [13]. Central to this debate are the 
recent reports that the bcl-2 oncogene, which has apoptosis- 
mitigating abilities, may similarly prevent lipid peroxidation 
[14,15]. 
We now demonstrate hat hydroperoxy fatty acids of the type 
common to membrane peroxidation are fully capable of elicit- 
ing all the major morphological nd chromatin changes associ- 
ated with apoptosis. When considered in the context of the 
recent reports that Bcl-2 expression may suppress lipid per- 
oxidation, these observations support he thesis that the inhibi- 
tion of apoptosis by bel-2 may be entirely attributable to this 
capacity. 
2. Materials and methods 
2.1. Cell lines and culture conditions 
The A3.01 human T cell line [16] and bcl-2 transfectants derived from 
it (see below) were cultured in RPMI 1640 supplemented with 10% 
heat-inactivated f tal bovine serum (FBS) and glutamine. Cultures were 
incubated at 37°C in a humidified incubator containing 6% 
COJ94% air. 
2.2. Tramfection with bcl-2 
A3.01 cells were transfected by electroporation with either an SFFV 
vector containing human bcl-2 cDNA under the control of a constitu- 
tive CMV promotor or the same vector in which the bcl-2 cDNA had 
been deleted that were obtained from Dr. S. Korsmeyer. Prior to trans- 
fection both plasmids were linearized by digestion with kpnl. Stable 
transfectants were selected based on their resistance to geneticin (600 
¢tg/ml) and cloned at 0.3 cells per well in the presence of the same. 
Clones were screened for Bcl-2 expression by immunofluorescence 
assay using a purified 6C8 hamster monoclonal ntibody specific for 
the human Bcl-2 protein [17] and developed with a fluorescein isothio- 
cyanate labeled goat anti-hamster antibody. Two separate clones each 
of Bcl-2 expressing and nonexpressing (vector only) were used. 
2.3. Viability assays 
The effects of lipid hydroperoxides and tumor necrosis factor<z 
(TNF-~) on cell viability were assayed using either [3H]thymidine 
([3H]Tdr) or MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy- 
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phenyl)-2-(4-sulfophe nyl)-2H-tetrazolium, inner salt) as described pre- 
viously [ 18,19]. 
2.4. Apoptosis assay 
Apoptosis was assayed by confirming the presence of ~ 180-bp DNA 
fragmentation by gel electrophoresis [20,21]. 
2.5. Measurement of cytoplasmic calcium 
A3.01 cells were collected by centrifugation, washed once in Ca2+-free 
buffer, and resuspended in the same buffer to yield a density of I × 107 
cells/ml. Fura-2/AM was added from a stock solution in DMSO to 
achieve a final concentration f 5 pM, and the cells were incubated at 
30°C for 30 min. The Fura-2-1oaded cells were washed twice with 
Ca2÷-free phosphate-buffered saline, followed by resupension i PBS 
containing Ca z÷. The cells were transferred toa cuvette containing 2 ml 
of PBS and maintained at 37°C for the duration of the assay. Fluores- 
cence measurements were performed using a Perkin Elmer LS 50 spec- 
trometer as described previously [22]. 
2.6. Electron microscopy 
Cultured cells were pelleted and fixed with 2.5% glutaraldehyde in 
0.1 M phosphate buffer for 1 h at 4°C, rinsed with phosphate buffer, 
and post-fixed with 1% osmium tetroxide for 1 h. Cells were then 
dehydrated through a series of graded alcohols, followed by propylene 
oxide. Cells were embedded in Epon/Araldite resin. Ultrathin tissue 
sections were obtained and counterstained with both lead citrate and 
uranyl acetate and viewed with a JEOL 100CX electron microscope. 
2.7. Reagents 
15-HPETE and 13-HPODE were prepared from arachidonic and 
linoleic acids (Sigma), respectively, and purified by HPLC [23]. MTS 
was provided by Dr. T.C. Owen [19] or purchased from Promega 
(Madison, WI). Fura-2 and BAPTA-AM were purchased from Molec- 
ular Probes (Eugene, OR), Geneticin was obtained from Boehringer 
Mannheim. 
3. Results 
As shown in Fig. 1, both 15-HPETE and 13-HPODE, hy- 
droperoxy derivatives of arachidonic and linoleic acids, respec- 
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Fig. 1. Susceptibility of A3.01 cells to killing by 15-HPETE and 13- 
HPODE. A3.01 cells were exposed to the indicated doses of either 
15-HPETE, 13-HPODE, or were left untreated. After 16 h, cell viabil- 
ities were assayed by measuring the incorporation of [3H]Tdr. The 
viabilities observed for each fatty acid treatment are expressed as the 
percentage of untreated control cells. 
Fig. 2. Nuclear changes induced by exposure to 15-HPETE. (A) A3.01 
cells exposed to 40/zM 15-HPETE for 3 h (7,699 × magnification); 
(B) untreated A3.01 cells (8,.166 x magnification). 
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Fig. 3. 15-HPETE-induced DNA fragmentation. A3.01 ceils were ex- 
posed to 40/zM 15-HPETE for the indicated periods of time, after 
which the cells were harvested and low-molecular-weight DNA was 
isolated and radiolabeled using Klenow fragment and [s2P]dCTP. The 
labeled DNA fragments were subsequently separated by gel electropho- 
resis and visualized by autoradiography. The extreme left lane corre- 
sponds to a 100-bp DNA ladder. 
tively, evoked dose-dependent toxicity when added to A3.01 
cells. Similar doses of either arachidonic acid or 15-hy- 
droxyeicosatetraenoic acid (15-HETE), the reduced form of 
15-HPETE had no effect on cell viability (data not shown), 
clearly associating cytotoxicity with the hydroperoxy moiety. 
Within 2 to 3 h after addition of 40 ¢tM 15-HPETE, nuclear 
condensation and fragmentation was obvious by phase-con- 
trast microscopy (data not shown). Electron microscopy re- 
vealed the presence of condensed, crescent-shaped chromatin 
associated with the nuclear membrane (Fig. 2A). Throughout 
these early stages of cell death, the plasma membrane and 
cellular organelles uch as the mitochondria remained intact, 
consistent with the cells undergoing apoptosis as opposed to 
necrosis. Nevertheless, ome morphological changes were ob- 
served within the cytoplasm of 15-HPETE-treated cells. Com- 
pared with control cells (Fig. 2B), the mitochondria of apop- 
totic cells were considerably more electron dense and there was 
a disappearance of cytoplasmic granularity that could be indic- 
ative of a loss of polyribosomes from the rough endoplasmic 
reticulum. These gross morphological changes coincided with 
the occurrence of DNA fragmentation, asdemonstrated by the 
appearance of a 180-bp DNA ladder that was detectable within 
2 h after the addition of 15-HPETE (Fig. 3). Collectively, these 
data clearly establish the ability of lipid hydroperoxides to elicit 
the major morphological changes associated with apoptosis. 
Elevation of cytoplasmic calcium ([Ca2+]~) has been reported 
to coincide with the initiation of apoptosis and in several mod- 
els is a requisite vent for the apoptotic response [24-26]. Lipid 
peroxidation has previously been reported to result in the eleva- 
tion of [Ca2+]~ [9,10], and consistent with this, A3.01 cells ex- 
posed to 40 ¢tM 15-HPETE displayed an immediate and sus- 
tained increase in [Ca:+]~ (Fig. 4). To determine if the rise in 
[Ca2+]i was required for lipid hydroperoxide-mediated popto- 
sis, A3.01 cells were preloaded with the cell-permeable calcium 
chelator, BAPTA-AM [27], followed by exposure to various 
concentrations of 15-HPETE. As shown in Fig. 5, pretreatment 
with 6/,tM BAPTA-AM resulted in a 4-fold increase in the 
amount of 15-HPETE required to kill 50% of A3.01 cells. Thus, 
the rise in [Ca2+]i is required for the induction of apoptotic 
death. 
It has been reported that Bcl-2 overexpression prevents 
apoptosis either by preventing the formation of lipid hydroper- 
oxides, or more directly, by protecting cells from the toxic 
effects of lipid hydroperoxides [14,15]. To distinguish between 
these two possibilities, A3.01 cells were stably transfected with 
human Bcl-2 and subsequently tested for their sensitivity to 
killing by TNF-c~ and 15-HPETE. TNF-~ was chosen due to 
the well-established role of reactive oxygen species (ROS) in 
mediating TNF-~ cytotoxicity [28-30], and the ability of Bcl-2 
to protect cells from TNF-c~-induced cell death [31]. Compared 
with A3.01 cells transfected with the control (empty) vector, the 
Bcl-2 transfectants were found to be 6-8 times more resistant 
to killing by TNF-~ (Fig. 6A), thereby confirming that the 
over-expressed Bcl-2 protein was functioning to inhibit apopto- 
sis. By contrast, when the Bcl-2 transfectants were induced to 
undergo apoptosis with various doses of 15-HPETE, they dis- 
played only a 25-50% increase in resistance over cells trans- 
fected with the vector alone (Fig. 6B). 
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Fig. 4. 15-HPETE-induced increase in cytosolic alcium. A3.01 cells 
loaded with Fura-2 were exposed to either 40/IM 15-HPETE or 0.2% 
EtOH as a vehicle control. Changes in [Ca2÷], were determined as 
described in section 2. 
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Fig. 5. Protection of A 3.01 cells from 15-HPETE-induced apoptosis by 
the intracellular calcium chelator, BAPTA-AM. A3.01 cells were har- 
vested by centrifugation and resuspended in Hanks balanced salt solu- 
tion lacking Ca -,+ but containing 6 #M BAPTA-AM. After 45 min, the 
cells were harvested, washed once in PBS, and resuspended in media 
containing 0 or 40 #M 15-HPETE. Three hours later, [3H]Tdr was 
added and incorporation i to cellular DNA was measured after 3 h. 
4. Discussion 
While there is considerable evidence implicating oxidative 
stress as a mediator of apoptosis [5,6,14,15,23,32 36], the un- 
derlying mechanisms have yet to be fully defined. The present 
study shows that at least one likely product of oxidative stress, 
lipid hydroperoxide, is capable of eliciting many cellular 
changes definitive of apoptosis, including DNA fragmentation 
and chromatin condensation, with the characteristic preserva- 
tion of plasma membrane and organelle integrity. These results 
clearly demonstrate hat lipid peroxides can act as mediators 
of apoptosis, and despite their notorious reputation, do not 
necessarily initiate an uncontrolled autocatalytic reaction cul- 
minating in massive cellular damage. Indeed, the selective de- 
struction of reticulocyte mitochondria during erythrocyte mat- 
uration may represent one case where lipid hydroperoxides 
serve as physiological mediators of apoptosis [37]. 
The mechanism by which lipid hydroperoxides licit apop- 
totic death is unclear. As demonstrated herein and in previous 
studies [9,10], the addition of lipid hydroperoxides results in a 
marked increase in [Ca~-+], that is essential for the induction of 
apoptosis. The origin of the calcium increase is not known. 
Lipid hydroperoxides may open calcium channels or act di- 
rectly as ionophores to facilitate ntry of extracellular calcium. 
Alternatively, they may stimulate the release of calcium from 
mitochondrial nd endoplasmic stores [10,11,37,38]. A rise in 
[Ca2+]~ could lead to the activation of various signal transduc- 
tion pathways that culminate in cell death [40]. In this regard 
it is interesting that Bcl-2 expression has been reported to in- 
hibit a calcium pump that is necessary for the capacitative 
release of Ca 2÷ from the endoplasmic reticulum [41]. A HPETE- 
mediated Ca 2+ influx would also be expected to result in the 
activation of the CaZ+-dependent donuclease r sponsible for 
cleavage of DNA at internucleosomal sites. It has recently been 
suggested that the form of cleavage which leads to the DNA 
fragmentation seen in apoptosis results from an accumulation 
of single-strand breaks [42]. While ROS, and in particular lipid 
hydroperoxides, are capable of generating single-strand DNA 
breaks [11], the addition of 15-HPETE to isolated A3.01 nuclei 
did not elicit DNA fragmentation (P.A. Sandstrom, unpub- 
lished observations). Such observations seem to argue against 
a direct effect of lipid hydroperoxides on either the endonu- 
clease or DNA. However, we cannot exclude the possibility that 
HPETE-generated single-strand DNA breaks elicit the activa- 
tion of poly-ADP ribose transferase similar to what has re- 
cently been reported for nitric oxide-initiated neurotoxicity 
[43]. The activation of this enzyme by single-strand DNA 
breaks results in the depletion of cellular energy supplies, thus 
augmenting cell death. 
The ability of Bcl-2 to protect cells from oxidative stress- 
mediated cytotoxicity, implies that the protein somehow func- 
tions to bolster cellular antioxidant defenses [14,15,44]. One 
notable consequence of Bcl-2 overexpression i  mammalian 
cells was decreased membrane lipid peroxidation [14]. Our data 
suggest that the ability of the bcl-2 proto-oncogene to block the 
formation of lipid peroxidation could account entirely for its 
capacity to inhibit oxidative stress-induced apoptosis. Such an 
effect could result from either a decreased formation or an 
increased etoxification of lipid peroxides, consistent with the 
protein's obligatory association with cellular membranes to 
inhibit apoptosis [45]. However, the results obtained in this 
study implicate the former alternative as being the case. As 
expected, based on previous studies [46], overexpression of
Bcl-2 in A3.01 cells afforded substantial protection from TNF- 
~, the cytotoxicity of which has been extensively linked to the 
formation of ROS [28-30] as well as either the availability or 
oxidation of arachidonic acid [46]. By contrast, the bcl-2 trans- 
fectants were found to be only slightly more resistant o 
15-HPETE-induced apoptosis than the control-transfected 
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Fig. 6. Effect of Bcl-2 overexpression on TNF-cc- and 15-HPETE- 
mediated cytotoxicity. Two bcl-2-transfected clones (closed symbols) 
and two control clones transfected with the empty vector (open sym- 
bols) were plated at 4 × 105 cells/ml in 2.5% FBS/RPMI and exposed 
to the indicated ose of either TNF-c~ or 15-HPETE. After 48 h cell 
viabilities were assayed using MTS. The viabilities are expressed as the 
percentage ofuntreated control cells. 
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A3.01 cells, implying that Bcl-2 overexpression did not endow 
the cells with a greater ability to survive exogenously derived 
lipid hydroperoxides. If Bcl-2 were acting directly to detoxify 
lipid hydroperoxides it would be expected that the fold increase 
in resistance to exogenous 15-HPETE would be more reflective 
of what is seen with TNFc~ cytotoxicity. The marginal resis- 
tance to 15-HPETE may indirectly result from a general shift 
in the basal redox status of the cells, incidentally allowing lipid 
hydroperoxides to be better tolerated. Alternatively, the de- 
composition of 15-HPETE may generate ROS which although 
present in minor amounts contribute to the observed cytotox- 
icity, and are detoxified by a Bcl-2 associated mechanism. It
therefore seems likely that Bcl-2 can effectively prevent the 
formation of lipid peroxides, but neither facilitates their meta- 
bolic detoxification or blocks their effects on the cell. 
In summary, we report here that hydroperoxy fatty acids are 
capable of mediating all of the major morphological nd chro- 
matin changes associated with what is accepted as an apoptotic 
phenotype, and so supports the proposed role of lipid peroxide 
intermediates in programmed cell death. When considered in 
the context of recent reports asserting that Bcl-2 mitigates 
apoptosis though the regulation of lipid peroxidation, our re- 
sults suggest that it may be at the level of lipid peroxide forma- 
tion rather than detoxification. 
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